UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000026048
Receipt No. R000029935
Official scientific title of the study Finite Element Analysis of bones affected by bone metastases
Date of disclosure of the study information 2017/02/17
Last modified on 2017/02/08 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Finite Element Analysis of bones affected by bone metastases
Title of the study (Brief title) Finite Element Analysis of bones affected by bone metastases
Region
Japan

Condition
Condition metastatic bone tumors
Classification by specialty
Orthopedics
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate risk of pathologic fracture for individual bone metastases using computed tomography data and finite element method
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Bone strength of the affected side relative to the other side and assumed fracture site computed using finite element method analysis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients with metastatic bone tumors
Key exclusion criteria not applicable
Target sample size 20

Research contact person
Name of lead principal investigator Jungo Imanishi
Organization Saitama Medical University International Medical Center
Division name Orthopaedic Oncology and Surgery
Address 1397-1 Yamane, Hidaka, Saitama
TEL 042-984-4111
Email jungo@saitama-med.ac.jp

Public contact
Name of contact person Jungo Imanishi
Organization Saitama Medical University International Medical Center
Division name Orthopaedic Oncology and Surgery
Address 1397-1 Yamane, Hidaka, Saitama
TEL 042-984-4111
Homepage URL
Email jungo@saitama-med.ac.jp

Sponsor
Institute Saitama Medical University
Institute
Department

Funding Source
Organization Saitama Medical University International Medical Center
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 02 Month 17 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 02 Month 08 Day
Anticipated trial start date
2017 Year 02 Month 08 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information This study starts on the 8th of Feb, 2017.

Management information
Registered date
2017 Year 02 Month 08 Day
Last modified on
2017 Year 02 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029935